Spontaneously resolved severe retinopathy associated with aplastic anemia.
1Ophthalmology, Sultan Qaboos University Hospital, Muscat, Sultanate of Oman.
Oman Journal of Ophthalmology
|August 4, 2021
Summary
Aplastic anemia can cause severe vision loss from retinopathy. Hematopoietic stem-cell transplantation led to significant vision improvement and retinopathy resolution in a young male patient.
Area of Science:
- Hematology
- Ophthalmology
- Stem Cell Transplantation
Background:
- Aplastic anemia is a rare bone marrow disorder causing pancytopenia.
- Ocular manifestations, including retinopathy, can be sight-threatening in aplastic anemia patients.
- Hemorrhagic retinopathy is a severe complication associated with aplastic anemia.
Purpose of the Study:
- To report a case of severe bilateral hemorrhagic retinopathy secondary to aplastic anemia.
- To evaluate the efficacy of allogenic hematopoietic stem-cell transplantation in treating this ocular complication.
Main Methods:
- A case study of a young male patient with aplastic anemia and severe hemorrhagic retinopathy.
- Treatment involved systemic allogenic hematopoietic stem-cell transplantation.
- Ocular outcomes and visual acuity were monitored post-transplantation.
Main Results:
- The patient presented with severe bilateral hemorrhagic retinopathy.
- Following hematopoietic stem-cell transplantation, spontaneous resolution of retinopathy was observed.
- Significant improvement in vision occurred over 16 weeks post-transplantation.
Conclusions:
- Allogenic hematopoietic stem-cell transplantation can be an effective treatment for hemorrhagic retinopathy in aplastic anemia.
- This case highlights the potential for visual recovery after successful stem cell transplantation.
- Early intervention with stem cell transplantation may prevent permanent vision loss in aplastic anemia patients with ocular complications.
